approved

Приложение 4 на ПЛС от 02.12.2019 г.

Unique identificator:  53fc082b-be08-4af0-9c74-7bdd43f3ba7b

Current version: 1

Displayed version: 1

Format: CSV

  • Created at: 2019-12-03 10:29:22
  • Created by: georgi_sivchev
  • Updated at: 2019-12-03 10:29:22
records per page
Order by:

ПОЗИТИВЕН ЛЕКАРСТВЕН СПИСЪК

Apixaban EU/1/11/619/002 ELIQUIS, Film coated tablet, 2.5, mg, Pack: 20 Bristol-Myers Squibb/Pfizer EEIG, Обединено Кралство Bristol-Myers Squibb S.R.L. Contrada Fontana del Ceraso 03012 Anagni, Frosinone, Italy 36.87 7.37 44.24 4% 1.47 38.34 7.67 46.01 16% 5.9 44.24 8.85 53.09 НСР-4899/22.10.2014; НСР-9829/21.07.2016 02.09.2016 02.09.2016 Неактивен 3265
Apixaban EU/1/11/619/002 ELIQUIS, Film coated tablet, 2.5, mg, Pack: 20 Bristol-Myers Squibb/Pfizer EEIG, Обединено Кралство Bristol-Myers Squibb S.R.L. Contrada Fontana del Ceraso 03012 Anagni, Frosinone, Italy 36.87 7.37 44.24 4% 1.47 38.34 7.67 46.01 16% 5.9 44.24 8.85 53.09 НСР-4899/22.10.2014; НСР-9829/21.07.2016 02.09.2016 02.09.2016 Неактивен 3265
Apixaban EU/1/11/619/002 ELIQUIS, Film coated tablet, 2.5, mg, Pack: 20 Bristol-Myers Squibb/Pfizer EEIG, Обединено Кралство Bristol-Myers Squibb S.R.L. Contrada Fontana del Ceraso 03012 Anagni, Frosinone, Italy 37.16 7.43 44.59 4% 1.49 38.65 7.73 46.38 16% 5.95 44.6 8.92 53.52 НСР-4899/22.10.2014 06.11.2014 06.11.2014 Неактивен 3265
Apixaban EU/1/11/619/002 ELIQUIS, Film coated tablet, 2.5, mg, Pack: 20 Bristol-Myers Squibb/Pfizer EEIG, Обединено Кралство Bristol-Myers Squibb S.R.L. Contrada Fontana del Ceraso 03012 Anagni, Frosinone, Italy 37.16 7.43 44.59 4% 1.49 38.65 7.73 46.38 16% 5.95 44.6 8.92 53.52 НСР-4899/22.10.2014 06.11.2014 06.11.2014 Неактивен 3265
Metoclopramide 20160367 Elitan, Solution for injection, 10 mg/2 ml, mg, Pack: 100 Medochemie Ltd., Кипър Medochemie Ltd., Кипър 97.79 19.56 117.35 4% 3.91 101.7 20.34 122.04 16% 15.65 117.35 23.47 140.82 НСР-12407/18.04.2017 и НСР-12549/28.04.2017 (предварително изпълнение) НСР-11549/26.01.2017 г. 11.02.2017 02.05.2017 Активен 15587
coagulation factor VIII (efmoroctocog alfa) EU/1/15/1046/004 Elocta, Powder and solvent for solution for injection, 1000, IU, Pack: 1 vial (powder)+1 pre-filled syringe (solvent) Swedish Orphan Biovitrum AB, Швеция Swedish Orphan Biovitrum AB (publ), Швеция 1224.78 244.96 1469.74 4% 10 1234.78 246.96 1481.74 16% 25 1259.78 251.96 1511.74 НСР-12362/18.04.2017; НСР-15073/23.02.2018; КП-54/19.06.2019 и НСР-17247/14.11.2018 02.08.2019 02.08.2019 Активен 15668
coagulation factor VIII (efmoroctocog alfa) EU/1/15/1046/004 Elocta, Powder and solvent for solution for injection, 1000, IU, Pack: 1 vial (powder)+1 pre-filled syringe (solvent) Swedish Orphan Biovitrum AB, Швеция Swedish Orphan Biovitrum AB (publ), Швеция 1224.78 244.96 1469.74 4% 10 1234.78 246.96 1481.74 16% 25 1259.78 251.96 1511.74 НСР-12362/18.04.2017; НСР-15073/23.02.2018; КП-54/19.06.2019 и НСР-17247/14.11.2018 02.08.2019 02.08.2019 Неактивен 15668
coagulation factor VIII (efmoroctocog alfa) EU/1/15/1046/001 Elocta, Powder and solvent for solution for injection, 250, IU, Pack: 1 vial (powder)+1 pre-filled syringe (solvent) Swedish Orphan Biovitrum AB, Швеция Swedish Orphan Biovitrum AB (publ), Швеция 306.2 61.24 367.44 4% 10 316.2 63.24 379.44 16% 25 341.2 68.24 409.44 НСР-12362/18.04.2017; НСР-15072/23.02.2018; КП-56/19.06.2019 и НСР-17249/14.11.2018 02.08.2019 02.08.2019 Активен 15666
coagulation factor VIII (efmoroctocog alfa) EU/1/15/1046/001 Elocta, Powder and solvent for solution for injection, 250, IU, Pack: 1 vial (powder)+1 pre-filled syringe (solvent) Swedish Orphan Biovitrum AB, Швеция Swedish Orphan Biovitrum AB (publ), Швеция 306.2 61.24 367.44 4% 10 316.2 63.24 379.44 16% 25 341.2 68.24 409.44 НСР-12362/18.04.2017; НСР-15072/23.02.2018; КП-56/19.06.2019 и НСР-17249/14.11.2018 02.08.2019 02.08.2019 Неактивен 15666
coagulation factor VIII (efmoroctocog alfa) EU/1/15/1046/001 Elocta, Powder and solvent for solution for injection, 250, IU, Pack: 1 vial (powder)+1 pre-filled syringe (solvent) Swedish Orphan Biovitrum AB, Швеция Swedish Orphan Biovitrum AB (publ), Швеция 316.84 63.37 380.21 4% 10 326.84 65.37 392.21 16% 25 351.84 70.37 422.21 НСР-12362/18.04.2017; НСР-15072/23.02.2018 10.03.2018 02.04.2018 Неактивен 15666
coagulation factor VIII (efmoroctocog alfa) EU/1/15/1046/004 Elocta, Powder and solvent for solution for injection, 1000, IU, Pack: 1 vial (powder)+1 pre-filled syringe (solvent) Swedish Orphan Biovitrum AB, Швеция Swedish Orphan Biovitrum AB (publ), Швеция 1267.38 253.48 1520.86 4% 10 1277.38 255.48 1532.86 16% 25 1302.38 260.48 1562.86 НСР-12362/18.04.2017; НСР-15073/23.02.2018 10.03.2018 02.04.2018 Неактивен 15668
coagulation factor VIII (efmoroctocog alfa) EU/1/15/1046/001 Elocta, Powder and solvent for solution for injection, 250, IU, Pack: 1 vial (powder)+1 pre-filled syringe (solvent) Swedish Orphan Biovitrum AB, Швеция Swedish Orphan Biovitrum AB (publ), Швеция 352.05 70.41 422.46 4% 10 362.05 72.41 434.46 16% 25 387.05 77.41 464.46 НСР-12362/18.04.2017 03.05.2017 02.06.2017 Неактивен 15666
coagulation factor VIII (efmoroctocog alfa) EU/1/15/1046/004 Elocta, Powder and solvent for solution for injection, 1000, IU, Pack: 1 vial (powder)+1 pre-filled syringe (solvent) Swedish Orphan Biovitrum AB, Швеция Swedish Orphan Biovitrum AB (publ), Швеция 1408.2 281.64 1689.84 4% 10 1418.2 283.64 1701.84 16% 25 1443.2 288.64 1731.84 НСР-12362/18.04.2017 03.05.2017 02.06.2017 Неактивен 15668
coagulation factor VIII (efmoroctocog alfa) EU/1/15/1046/002 Elocta, Powder and solvent for solution for injection, 500, IU, Pack: 1 vial (powder)+ 1 pre-filled syringe (solvent) Swedish Orphan Biovitrum AB, Швеция Swedish Orphan Biovitrum AB (publ), Швеция 612.39 122.48 734.87 4% 10 622.39 124.48 746.87 16% 25 647.39 129.48 776.87 НСР-12362/18.04.2017; НСР-13653/01.09.2017; КП-55/19.06.2019 и НСР-17248/14.11.2018 02.08.2019 02.08.2019 Активен 15667
coagulation factor VIII (efmoroctocog alfa) EU/1/15/1046/002 Elocta, Powder and solvent for solution for injection, 500, IU, Pack: 1 vial (powder)+ 1 pre-filled syringe (solvent) Swedish Orphan Biovitrum AB, Швеция Swedish Orphan Biovitrum AB (publ), Швеция 612.39 122.48 734.87 4% 10 622.39 124.48 746.87 16% 25 647.39 129.48 776.87 НСР-12362/18.04.2017; НСР-13653/01.09.2017; КП-55/19.06.2019 и НСР-17248/14.11.2018 02.08.2019 02.08.2019 Неактивен 15667
coagulation factor VIII (efmoroctocog alfa) EU/1/15/1046/002 Elocta, Powder and solvent for solution for injection, 500, IU, Pack: 1 vial (powder)+ 1 pre-filled syringe (solvent) Swedish Orphan Biovitrum AB, Швеция Swedish Orphan Biovitrum AB (publ), Швеция 633.69 126.74 760.43 4% 10 643.69 128.74 772.43 16% 25 668.69 133.74 802.43 НСР-12362/18.04.2017; НСР-13653/01.09.2017 16.09.2017 02.10.2017 Неактивен 15667
coagulation factor VIII (efmoroctocog alfa) EU/1/15/1046/002 Elocta, Powder and solvent for solution for injection, 500, IU, Pack: 1 vial (powder)+ 1 pre-filled syringe (solvent) Swedish Orphan Biovitrum AB, Швеция Swedish Orphan Biovitrum AB (publ), Швеция 704.1 140.82 844.92 4% 10 714.1 142.82 856.92 16% 25 739.1 147.82 886.92 НСР-12362/18.04.2017 02.06.2017 02.06.2017 Неактивен 15667
coagulation factor VIII (efmoroctocog alfa) EU/1/15/1046/007 Elocta, Powder and solvent for solution for injection, 3000, IU, Pack: 1 vial (powder) +1 pre-filled syringe (solvent) Swedish Orphan Biovitrum AB, Швеция Swedish Orphan Biovitrum AB (publ), Швеция 3674.36 734.87 4409.23 4% 10 3684.36 736.87 4421.23 16% 25 3709.36 741.87 4451.23 НСР-15271/16.03.2018 Предварително изпълнение; КП-51/19.06.2019 и НСР-17244/14.11.2018 02.08.2019 02.08.2019 Активен 16051
coagulation factor VIII (efmoroctocog alfa) EU/1/15/1046/007 Elocta, Powder and solvent for solution for injection, 3000, IU, Pack: 1 vial (powder) +1 pre-filled syringe (solvent) Swedish Orphan Biovitrum AB, Швеция Swedish Orphan Biovitrum AB (publ), Швеция 3674.36 734.87 4409.23 4% 10 3684.36 736.87 4421.23 16% 25 3709.36 741.87 4451.23 НСР-15271/16.03.2018 Предварително изпълнение; КП-51/19.06.2019 и НСР-17244/14.11.2018 02.08.2019 02.08.2019 Неактивен 16051
coagulation factor VIII (efmoroctocog alfa) EU/1/15/1046/006 Elocta, Powder and solvent for solution for injection, 2000, IU, Pack: 1 vial (powder) +1 pre-filled syringe (solvent) Swedish Orphan Biovitrum AB, Швеция Swedish Orphan Biovitrum AB (publ), Швеция 2449.56 489.91 2939.47 4% 10 2459.56 491.91 2951.47 16% 25 2484.56 496.91 2981.47 НСР-15271/16.03.2018 Предварително изпълнение; КП-52/19.06.2019 и НСР-17245/14.11.2018 02.08.2019 02.08.2019 Активен 16050
coagulation factor VIII (efmoroctocog alfa) EU/1/15/1046/006 Elocta, Powder and solvent for solution for injection, 2000, IU, Pack: 1 vial (powder) +1 pre-filled syringe (solvent) Swedish Orphan Biovitrum AB, Швеция Swedish Orphan Biovitrum AB (publ), Швеция 2449.56 489.91 2939.47 4% 10 2459.56 491.91 2951.47 16% 25 2484.56 496.91 2981.47 НСР-15271/16.03.2018 Предварително изпълнение; КП-52/19.06.2019 и НСР-17245/14.11.2018 02.08.2019 02.08.2019 Неактивен 16050
coagulation factor VIII (efmoroctocog alfa) EU/1/15/1046/005 Elocta, Powder and solvent for solution for injection, 1500, IU, Pack: 1 vial (powder) +1 pre-filled syringe (solvent) Swedish Orphan Biovitrum AB, Швеция Swedish Orphan Biovitrum AB (publ), Швеция 1837.17 367.43 2204.6 4% 10 1847.17 369.43 2216.6 16% 25 1872.17 374.43 2246.6 НСР-15271/16.03.2018 Предварително изпълнение; КП-53/19.06.2019 и НСР-17246/14.11.2018 02.08.2019 02.08.2019 Активен 16049
coagulation factor VIII (efmoroctocog alfa) EU/1/15/1046/005 Elocta, Powder and solvent for solution for injection, 1500, IU, Pack: 1 vial (powder) +1 pre-filled syringe (solvent) Swedish Orphan Biovitrum AB, Швеция Swedish Orphan Biovitrum AB (publ), Швеция 1837.17 367.43 2204.6 4% 10 1847.17 369.43 2216.6 16% 25 1872.17 374.43 2246.6 НСР-15271/16.03.2018 Предварително изпълнение; КП-53/19.06.2019 и НСР-17246/14.11.2018 02.08.2019 02.08.2019 Неактивен 16049
coagulation factor VIII (efmoroctocog alfa) EU/1/15/1046/005 Elocta, Powder and solvent for solution for injection, 1500, IU, Pack: 1 vial (powder) +1 pre-filled syringe (solvent) Swedish Orphan Biovitrum AB, Швеция Swedish Orphan Biovitrum AB (publ), Швеция 1901.07 380.21 2281.28 4% 10 1911.07 382.21 2293.28 16% 25 1936.07 387.21 2323.28 НСР-15271/16.03.2018 Предварително изпълнение 16.03.2018 02.04.2018 Неактивен 16049
coagulation factor VIII (efmoroctocog alfa) EU/1/15/1046/007 Elocta, Powder and solvent for solution for injection, 3000, IU, Pack: 1 vial (powder) +1 pre-filled syringe (solvent) Swedish Orphan Biovitrum AB, Швеция Swedish Orphan Biovitrum AB (publ), Швеция 3802.13 760.43 4562.56 4% 10 3812.13 762.43 4574.56 16% 25 3837.13 767.43 4604.56 НСР-15271/16.03.2018 Предварително изпълнение 16.03.2018 02.04.2018 Неактивен 16051
Showing 4426 to 4451 of 16785 entries
Download link in CSV format: Copy
Download link in JSON format: Copy
Download link in XML format: Copy
 

Моля изчакайте